Factor XIII mutation analysis

Definition

Biallelic variants in F13A1 (responsible for the majority of hereditary deficiencies) or, more rarely, in F13B render factor XIII, the transglutaminase enzyme that stabilizes the clot, nonfunctional. Factor XIII levels are typically below 5 percent of normal; delayed umbilical cord bleeding, soft tissue or intracranial hemorrhage, and impaired wound healing are observed.

Gene/region examined

FXIII - V34L

Method

Sequence analysis

Accepted sample types

EDTA blood, AF, CVS

Inheritance

Hereditary, autosomal recessive.

Related Tests